Aprizon
7-[4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 60795.
Registration
- Applicants
- 1
- Registrations
- 4
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Unicorn Pharmaceuticals (Pty) Ltd | Aprizon | 5, 10, 15, 30 | 510654.65, 510655.651, 510656.652, 510657.653 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Aprizon 5 EACH TABLET CONTAINS :ARIPIPRAZOLE 5,0 mg | 5 | 510654.6551/2.6.5/0654.650 | Registered | Not determined | None |
| Aprizon 10 EACH TABLET CONTAINS :ARIPIPRAZOLE 10,0 mg | 10 | 510655.65151/2.6.5/0655.651 | Registered | Not determined | None |
| Aprizon 15 EACH TABLET CONTAINS :ARIPIPRAZOLE 15,0 mg | 15 | 510656.65251/2.6.5/0656.652 | Registered | Not determined | None |
| Aprizon 30 EACH TABLET CONTAINS :ARIPIPRAZOLE 30,0 mg | 30 | 510657.65351/2.6.5/0657.653 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.